Innovative Industrial Properties, Inc. 9.00% Series A Cumulative Redeemable Preferred Stock

For the first quarter, Innovative Industrial Properties reported total revenues of $69 million, up 3.5% sequentially, with the increase primarily driven by $3.2 million of payments from PharmaCann and $1.5 million of Gold Flora settlement proceeds. AFFO was $53.4 million, or $1.88 per share, flat versus the fourth quarter of 2025. As of March 31, liquidity was approximately $177 million, including $89 million of cash and $87.5 million of revolver availability, with debt service coverage above 11x and net debt to adjusted EBITDA of 1.1x. For forward funding needs, management said it has raised $128 million year-to-date and is pursuing nearly $130 million of additional secured and unsecured financings, including a $56.5 million financing expected to fund today, to address the bond maturity due this month and support future growth.

Alan Gold framed the quarter around two themes: disciplined capital management and a potentially important industry reset from Schedule III. He said the company is positioning itself with a stronger balance sheet, additional financing flexibility, and a diversified platform across cannabis and life science. His tone was constructive and opportunistic, emphasizing that the company is prepared to pursue growth once the bond maturity and IQHQ funding obligations are behind it.

David Smith focused on the near-term maturity wall and the company’s funding plan. He detailed $128 million of gross capital raised year-to-date, made up of $72 million of preferred equity, $36 million of common equity and $20 million of secured debt from a 3-year term loan at a fixed 9% rate, and said the additional contemplated financings would carry a blended rate of just over 8%. He also highlighted $177 million of liquidity at quarter-end, the debt service coverage ratio exceeding 11x, and net debt to adjusted EBITDA of 1.1x, saying the balance sheet is positioned for growth in 2026.

Analysts pressed on how quickly signed but not yet commenced leases will contribute, and management said timing varies because of regulatory approvals, license transfers and free-rent periods that can range from 3 months to 12 to 18 months. They also asked whether Schedule III would eliminate future credit issues; Paul Smithers said it improves operating conditions but does not remove ordinary business risk. On the regulatory side, management said rescheduling does not address interstate commerce or banking, and that any meaningful interstate-commerce scenario is still many years away. On IQHQ, Alan Gold said the investment schedule runs through mid-2027 and that some payments may be brought forward opportunistically because the returns are attractive relative to the company’s cost of capital.